MARKET WIRE NEWS
  1. Home
  2. Stock
  3. AKTS
  4. News
AKTS
Quote
Short
News
Articles
Message Board

Aktis Oncology Inc. (NASDAQ : AKTS ) News

Aktis Oncology Inc. (NASDAQ: AKTS) News Releases

AKTS News Releases
AKTS : NASDAQ
KlickAnalytics
AKTS Price Target Alert: $35.00. Issued by H.C. Wainwright
AKTS : NASDAQ
KlickAnalytics
Buy Recommendation Issued On AKTS By H.C. Wainwright
AKTS : NASDAQ
GlobeNewswire
Aktis Oncology to Present at the Jefferies Global Healthcare Conference
AKTS : NASDAQ
GlobeNewswire
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
AKTS : NASDAQ
Motley Fool
Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company
AKTS : NASDAQ
SeekingAlpha
Aktis Oncology, Inc. reports Q1 results
AKTS : NASDAQ
GlobeNewswire
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
AKTS : NASDAQ
GlobeNewswire
Aktis Oncology to Present at the BofA Securities Health Care Conference
AKTS : NASDAQ
GlobeNewswire
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
AKTS : NASDAQ
SeekingAlpha
Aktis Oncology: 'Buy' Based On Radiotherapeutic Isotope Design For Broad Targeting
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.